Kyle J. Korshavn

Kyle J. Korshavn

Auto-generated profile, based on publicly available information

Kyle J. Korshavn

Department of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Environmental Science & Technology
Verified
Journal Article
Closed access
GYGe Yu
Ge Yu
ABAmanda R. Bayer
Amanda R. Bayer
MGMelissa M. Galloway
Melissa M. Galloway
KKKyle J. Korshavn
Kyle J. Korshavn
CFCharles G. Fry
Charles G. Fry
FKFrank N. Keutsch
Frank N. Keutsch

1 March 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KKKyle J. Korshavn
Kyle J. Korshavn
Cristina SatrianoCristina Satriano
Cristina Satriano
YLYuxi Lin
Yuxi Lin
RZRongchun Zhang
Rongchun Zhang
MDMark Dulchavsky
Mark Dulchavsky
Ayyalusamy RamamoorthyAyyalusamy Ramamoorthy
Ayyalusamy Ramamoorthy
The aggregation of amyloid-β (Aβ) on lipid bilayers has been implicated as a mechanism by which Aβ exerts its toxicity in Alzheimer's disease (AD). Lipid bilayer thinning has been observed during both oxidative stress and protein aggregation in AD, but whether these pathological modifications of the bilayer correlate with Aβ misfolding is unclear. Here, we studied peptide-lipid interactions in synthetic bilayers of the short-chain lipid dilauroyl phosphatidylcholine (DLPC) as a simplified model for diseased bilayers to determine their impact on Aβ aggregate, protofibril, and fibril formation. Aβ aggregation and fibril formation in membranes composed of dioleoyl phosphatidylcholine (DOPC) or 1- palmitoyl-2-oleoyl phosphatidylcholine mimicking normal bilayers served as controls. Differences in aggregate formation and stability were monitored by a combination of thioflavin-T fluorescence, circular dichroism, atomic force microscopy, transmission electron microscopy, and NMR. Despite the ability of all three lipid bilayers to catalyze aggregation, DLPC accelerates aggregation at much lower concentrations and prevents the fibrillation of Aβ at low micromolar concentrations. DLPC stabilized globular, membrane-associated oligomers, which could disrupt the bilayer integrity. DLPC bilayers also remodeled preformed amyloid fibrils into a pseudo-unfolded, molten globule state, which resembled on-pathway, protofibrillar aggregates. Whereas the stabilized, membrane-associated oligomers were found to be nontoxic, the remodeled species displayed toxicity similar to that of conventionally prepared aggregates. These results provide mechanistic insights into the roles that pathologically thin bilayers may play in Aβ aggregation on neuronal bilayers, and pathological lipid oxidation may contribute to Aβ misfolding.

5 June 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
MJMichael R. Jones
Michael R. Jones
Emilie MathieuEmilie Mathieu
Emilie Mathieu
CDChristine Dyrager
Christine Dyrager
SFSimon Faissner
Simon Faissner
ZVZavier Vaillancourt
Zavier Vaillancourt
TSTim Storr
Tim Storr
Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) plaque deposits. Increased oxidative stress, metal ion dysregulation, and the formation of toxic Aβ peptide oligomers are all considered to contribute to the etiology of AD. In this work we have developed a series of ligands that are multi-target-directed in order to address several disease properties. 2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)phenol (POH), 2-(1-(2-morpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PMorph), and 2-(1-(2-thiomorpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PTMorph) have been synthesized and screened for their antioxidant capacity, Cu-binding affinity, interaction with the Aβ peptide and modulation of Aβ peptide aggregation, and the ability to limit Aβ1–42-induced neurotoxicity in human neuronal culture. The synthetic protocol and structural variance incorporated via click chemistry, highlights the influence of R-group modification on ligand-Aβ interactions and neuroprotective effects. Overall, this study demonstrates that the phenol–triazole ligand scaffold can target multiple factors associated with AD, thus warranting further therapeutic development.

8 April 2014 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
Hyuck Jin LeeHyuck Jin Lee
Hyuck Jin Lee
KKKyle J. Korshavn
Kyle J. Korshavn
AKAkiko Kochi
Akiko Kochi
JDJeffrey S. Derrick
Jeffrey S. Derrick
MLMi Hee Lim
Mi Hee Lim
Cholesterol and metal ions have been suggested to be associated with the onset and progression of Alzheimer's disease (AD). Moreover, recent findings have demonstrated a potential interconnection between these two factors. For example, (a) cholesterol has been shown to be misregulated in AD-afflicted brains, and the aberrant activity of proteins (particularly, apolipoprotein E (ApoE) and 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGR)) has been linked to cholesterol-related AD exacerbation; (b) dyshomeostasis of metal ions associated with misfolded proteins (i.e., amyloid-β (Aβ) aggregates) found in the brains of AD patients is shown to promote oxidative stress leading to the malfunction of multiple proteins, including cytochrome c oxidase (CcO), and Cu/Zn superoxide dismutase (SOD1); (c) metal ion misregulation has also been observed to disrupt the activity of proteins (e.g., HMGR, low-density lipoproteins (LDL)), required for cholesterol production and regulation. Herein, we briefly discuss the potential involvement of cholesterol and metal ions in AD neuropathogenesis in both individual and interrelated manners.

6 November 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
KKKyle J. Korshavn
Kyle J. Korshavn
ABAnirban Bhunia
Anirban Bhunia
MLMi Hee Lim
Mi Hee Lim
Ayyalusamy RamamoorthyAyyalusamy Ramamoorthy
Ayyalusamy Ramamoorthy
Aggregation at the neuronal cell membrane's lipid bilayer surface is implicated in amyloid-β (Aβ) toxicity associated with Alzheimer's disease; however, structural and mechanistic insights into the process remain scarce. We have identified a conserved binding mode of Aβ40 on lipid bilayer surfaces with a conserved helix containing the self-recognition site (K16-E22).

17 November 2017 in eLife
Verified
Journal Article
Open access
DCDiana C Rodriguez Camargo
Diana C Rodriguez Camargo
KKKyle J Korshavn
Kyle J Korshavn
AJAlexander Jussupow
Alexander Jussupow
KRKolio Raltchev
Kolio Raltchev
DGDavid Goricanec
David Goricanec
Ayyalusamy RamamoorthyAyyalusamy Ramamoorthy
Ayyalusamy Ramamoorthy
Membrane-assisted amyloid formation is implicated in human diseases, and many of the aggregating species accelerate amyloid formation and induce cell death. While structures of membrane-associated intermediates would provide tremendous insights into the pathology and aid in the design of compounds to potentially treat the diseases, it has not been feasible to overcome the challenges posed by the cell membrane. Here, we use NMR experimental constraints to solve the structure of a type-2 diabetes related human islet amyloid polypeptide intermediate stabilized in nanodiscs. ROSETTA and MD simulations resulted in a unique β-strand structure distinct from the conventional amyloid β-hairpin and revealed that the nucleating NFGAIL region remains flexible and accessible within this isolated intermediate, suggesting a mechanism by which membrane-associated aggregation may be propagated. The ability of nanodiscs to trap amyloid intermediates as demonstrated could become one of the most powerful approaches to dissect the complicated misfolding pathways of protein aggregation.